Pharmacokinetics of Rivaroxaban After Bariatric Surgery
Condition(s):Bariatric Surgery; Morbid ObesityLast Updated:July 21, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Bariatric Surgery; Morbid ObesityLast Updated:July 21, 2022Completed
Condition(s):Rivaroxaban; Cancer-associated Thrombosis; Recurrence; BleedingLast Updated:January 9, 2017Completed
Condition(s):Anemia; Venous ThrombosisLast Updated:November 8, 2019Completed
Condition(s):Acute Coronary Syndrome; Venous Thrombosis; Pulmonary Embolism; Atrial FibrillationLast Updated:September 27, 2021Completed
Condition(s):Atrial Fibrillation; Anticoagulant Adverse Reaction; Stroke; Major Adverse Cardiac EventsLast Updated:October 31, 2023Not yet recruiting
Condition(s):Antiphospholipid SyndromeLast Updated:January 30, 2018Terminated
Condition(s):Post Coronary Bypass Surgery PatientsLast Updated:September 6, 2023Completed
Condition(s):Sickle Cell Anemia; Sickle Cell-Beta0-ThalassemiaLast Updated:April 13, 2020Completed
Condition(s):Patients Receiving Rivaroxaban TreatmentLast Updated:February 14, 2017Completed
Condition(s):Left Ventricular ThrombusLast Updated:August 2, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.